Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. by Seitz, Dallas P et al.
Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias
within a primary care setting
Review information
Review type: Diagnostic test accuracy
Review number: DTA 12
Authors
Dallas P Seitz1, Calvin CH Chan2, Hailey T Newton1, Sudeep S Gill3, Nathan Herrmann4, Nadja Smailagic5, Vasilis
Nikolaou6, Bruce A Fage7
1Department of Psychiatry, Queen's University, Kingston, Canada
2School of Medicine, Queen's University, Kingston, Canada
3Department of Medicine, Queen's University, Kingston, Canada
4Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, Canada
5Institute of Public Health, University of Cambridge, Cambridge, UK
6Research In Real Life, Cambridge, UK
7Department of Psychiatry, University of Toronto, Toronto, Canada
Citation example: Seitz DP, Chan CCH, Newton HT, Gill SS, Herrmann N, Smailagic N, Nikolaou V, Fage BA. Mini-Cog
for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting. Cochrane
Database of Systematic Reviews 2018 , Issue 2 . Art. No.: CD011415. DOI: 10.1002/14651858.CD011415.pub2 .
Contact person
Dallas P Seitz
Assistant Professor
Department of Psychiatry
Queen's University
752 King Street West
Kingston
ON
K7L 4X3
Canada
E-mail: seitzd@providencecare.ca
Dates
Assessed as Up-to-date:31 January 2017
Date of Search: 31 January 2017
Next Stage Expected: 31 January 2019
Protocol First Published: Issue 12 , 2014
Review First Published: Issue 2 , 2018
Last Citation Issue: Issue 2 , 2018
What's new
Date Event Description
History
Date Event Description
Abstract
Background
Alzheimer's disease and other forms of dementia are becoming increasingly common with the aging of most populations.
The majority of individuals with dementia will first present for care and assessment in primary care settings. There is a need
for brief dementia screening instruments that can accurately diagnose dementia in primary care settings. The Mini-Cog is a
brief, cognitive screening test that is frequently used to evaluate cognition in older adults in various settings.
Objectives
To determine the diagnostic accuracy of the Mini-Cog for diagnosing Alzheimer’s disease dementia and related dementias in
a primary care setting.
Search methods
We searched the Cochrane Dementia and Cognitive Improvement Register of Diagnostic Test Accuracy Studies, MEDLINE,
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Embase and four other databases, initially to September 2012. Since then, four updates to the search were performed using
the same search methods, and the most recent was January 2017. We used citation tracking (using the databases' ‘related
articles’ feature, where available) as an additional search method and contacted authors of eligible studies for unpublished
data.
Selection criteria
We only included studies that evaluated the Mini-Cog as an index test for the diagnosis of Alzheimer's disease dementia or
related forms of dementia when compared to a reference standard using validated criteria for dementia. We only included
studies that were conducted in primary care populations.
Data collection and analysis
We extracted and described information on the characteristics of the study participants and study setting. Using the Quality
Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria we evaluated the quality of studies, and we assessed risk
of bias and applicability of each study for each domain in QUADAS-2. Two review authors independently extracted
information on the true positives, true negatives, false positives, and false negatives and entered the data into Review
Manager 5 (RevMan 5). We then used RevMan 5 to determine the sensitivity, specificity, and 95% confidence intervals. We
summarized the sensitivity and specificity of the Mini-Cog in the individual studies in forest plots and also plotted them in a
receiver operating characteristic plot. We also created a 'Risk of bias' and applicability concerns graph to summarize
information related to the quality of included studies.
Main results
There were a total of four studies that met our inclusion criteria, including a total of 1517 total participants. The
sensitivity of the Mini-Cog varied between 0.76 to 1.00 in studies while the specificity varied between 0.27 to 0.85.
The included studies displayed significant heterogeneity in both methodologies and clinical populations, which did
not allow for a meta-analysis to be completed. Only one study (Holsinger 2012) was found to be at low risk of bias on all
methodological domains. The results of this study reported that the sensitivity of the Mini-Cog was 0.76 and the specificity
was 0.73. We found the quality of all other included studies to be low due to a high risk of bias with methodological limitations
primarily in their selection of participants.
Authors' conclusions
There is a limited number of studies evaluating the accuracy of the Mini-Cog for the diagnosis of dementia in primary care
settings. Given the small number of studies, the wide range in estimates of the accuracy of the Mini-Cog, and methodological
limitations identified in most of the studies, at the present time there is insufficient evidence to recommend that the Mini-Cog
be used as a screening test for dementia in primary care. Further studies are required to determine the accuracy of Mini-Cog
in primary care and whether this tool has sufficient diagnostic test accuracy to be useful as a screening test in this setting.
Plain language summary
How accurate is the mini-cog test when used to assess dementia in general practice?
Background and rationale for review
In most parts of the world there are increasing numbers of older adults, and memory complaints and conditions such as
Alzheimer's disease and other forms of dementia are becoming increasingly common as a result. Most individuals with
memory difficulties will first seek out care or be identified in the healthcare system through their primary care health care
providers, which may include family physicians or nurses. Therefore, there is a need for tools that could identify individuals
who may have dementia or significant memory problems. These tools should also be able to rule out dementia in those
individuals with memory complaints who do not have dementia or significant memory problems. Such tools in primary care
must be relatively easy to use, quick to administer, and accurate so as to be feasible to use in primary care while at the same
time not overdiagnose or underdiagnose dementia. The Mini-Cog, a brief cognitive screening tool, has been suggested as a
possible screening test for dementia in primary care as it has been reported to be accurate and relatively easy to administer
in primary care settings. The Mini-Cog consists of a memory task that involves recall of three words and an evaluation of a
clock drawing task.
Study characteristics
We searched electronic databases for articles evaluating the Mini-Cog and this evidence is current as of January 2017. The
purpose of our review was to compare the accuracy of the Mini-Cog for diagnosing dementia of any type in primary care
settings when compared to in-depth evaluation conducted by dementia specialists. We included studies that evaluated
individuals with any potential severity of dementia and regardless of whether previous cognitive testing had been completed
prior to the Mini-Cog. Overall, our review identified four studies conducted in primary care settings that compared the
accuracy of the Mini-Cog to detailed assessment of dementia by dementia specialists.
Quality of the evidence
Of the four studies included in the review, all except one study had limitations in how the Mini-Cog was evaluated, which may
have led to an overestimation of the accuracy of the Mini-Cog in the remaining studies. Notably, the most problematic issue
in study quality related to how participants were selected to participate in research studies, which may have further
contributed to an overestimation of the accuracy of the Mini-Cog in most of the studies included in our review.
Key findings
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The results of the highest-quality study Holsinger 2012 found that the Mini-Cog had a sensitivity of 76%, indicating that the
Mini-Cog failed to detect up to 24% of individuals who have dementia (e.g. false negatives). In this same study, the specificity
of the Mini-Cog was 73% indicating that up to 27% of individuals may be incorrectly identified as having dementia on the
Mini-Cog when these individuals do not actually have an underlying dementia (e.g. false positives). We conclude that at the
present time there is not enough evidence to support the routine use of the Mini-Cog as a screening test for dementia in
primary care and additional studies are required before concluding that the Mini-Cog is useful in this setting.
Background 
Target condition being diagnosed
Alzheimer's disease and related forms of dementia are common among older adults with a prevalence of 8% in
individuals aged over 65 years and increasing to a prevalence of approximately 43% in adults aged 85 years and older
(Thies 2012). Given the increasing number of older adults in most developing countries, the prevalence of dementia is
expected to increase considerably in the coming years (Ferri 2005). Alzheimer's disease and related forms of dementia
are currently incurable and result in considerable direct and indirect costs, both in terms of formal health care and lost
productivity from both the affected individuals and their caregivers (Thies 2012). There is a debate as to the value of
arriving at a diagnosis of dementia earlier in the disease process. Diagnosing Alzheimer's disease in the pre-clinical state
using biomarker or neuroimaging modalities without the availability of effective treatments or interventions to alter the
disease course may be harmful in some situations (Le Couteur 2013). However, qualitative research has
demonstrated that many individuals with clinically diagnosed dementia and their caregivers would prefer to know a
diagnosis of dementia early in the disease process, as knowledge of the diagnosis of dementia can help to facilitate a
better understanding of observed cognitive and functional changes and facilitate more timely access to supports and
services (Prorok 2013; Prorok 2016). A diagnosis of dementia is necessary to access certain services and supports for
individuals and their caregivers; and pharmacological treatments such as cholinesterase inhibitors (Birks 2006; Rolinski
2012) or memantine (McShane 2009; Wilkinson 2012) have only been shown to be effective in providing temporary
symptomatic improvement in cognitive function for individuals diagnosed with mild to moderate Alzheimer's disease.
The diagnosis of Alzheimer's disease is clinical and based on a history of progressive decline in cognition affecting
memory and at least one other area of cognitive functioning (e.g. apraxia, agnosia, or executive dysfunction). There
must be a decline from a previous level of functioning resulting in significant social or occupational impairment (APA 2000; 
APA 2013; McKhann 2001). A definitive diagnosis of Alzheimer's disease can only be achieved at autopsy but a
clinical diagnosis using standardized criteria is associated with a sensitivity of 81% and a specificity of 70% when
compared to autopsy-proven cases (Knopman 2001; Nagy 1998).
Approximately 50% to 80% of all individuals with dementia are ultimately classified as having Alzheimer's disease (Blennow
2006; Brunnstrom 2009; Canadian Study of Health and Aging 1994). Vascular dementias may occur more
abruptly or present with a step-wise decline in cognition over time and account for approximately 15% to 20% of
dementias (Brunnstrom 2009; Canadian Study of Health and Aging 1994; Feldman 2003; Lobo 2000). Dementia
with a mixed Alzheimer's disease and vascular pathology is present in 10% to 30% of cases (Brunnstrom 2009; Crystal
2000; Feldman 2003). Less frequent causes of dementia include dementia with Lewy bodies (Brunnstrom 2009) or
Parkinson's disease dementia (Aarsland 2005). People experiencing frontotemporal dementia account for a
smaller proportion of dementias (4% to 8%) and often present with problems in executive function and changes
in behaviour, while memory is relatively preserved (Brunnstrom 2009; Grecicus 2002).
Index test(s)
The Mini-Cog is a brief cognitive screening test consisting of two components, a delayed, three-word recall task and
the clock drawing test (Borson 2000). The Mini-Cog was initially examined in community settings and was
designed to provide a relatively brief cognitive screening test that was free of educational and cultural biases.
Different scoring algorithms were tested to determine which combination had the optimal balance of sensitivity and
specificity (McCarten 2011; Scanlan 2001). The Mini-Cog takes approximately three to five minutes to complete in
routine practice (Borson 2000; Holsinger 2007; Scanlan 2001). The Mini-Cog has been reported to have little potential
for bias as a result of education or language (Borson 2000; Borson 2005).
Clinical Pathway 
Dementia typically begins with subtle cognitive changes and progresses gradually over the course of several
years. Most older adults with memory complaints will first present to their general practitioner or other primary care
healthcare provider (for example nurses or a nurse practitioner). There is a presumed period when people are
asymptomatic, although the disease pathology may be progressing. Individuals or their relatives may first notice
subtle impairments of short-term memory or other areas of cognitive functioning. Gradually, additional cognitive
deficits become apparent resulting in difficulty completing complex activities of daily living such as the management
of finances and medications, or operating motor vehicles (Njegovan 2001). The attribution of cognitive symptoms to
normal aging may cause delays in the diagnosis and treatment of Alzheimer's disease or other types of dementia (Prorok
2013). Therefore, there is a need for accurate brief dementia screening tests to help distinguish between the
cognitive changes associated with normal aging and changes that might indicate dementia. Individuals with
dementia often first present to primary care health care providers with cognitive complaints or functional changes
that might indicate the possibility of a dementia (Feldman 2008). Even though most individuals with dementia are
first evaluated in primary care, the absence of systematic dementia screening programs for dementia in many
primary care settings may result in an underdiagnosis of individuals with dementia (Connolly 2011).
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Prior test(s)
As the Mini-Cog is recommended to be used as an initial screening test for dementia in primary care (Brodaty 2006; Ismail
2010; Milne 2008; Tsoi 2015) it is unlikely that individuals will have had any testing completed prior to the administration of
the Mini-Cog.
Role of index test(s)
Primary healthcare providers may administer brief cognitive screening tests and, depending on the results of the initial
tests, an individual may then have additional investigations or cognitive tests to confirm if a diagnosis of dementia is
present. In some settings, a positive result on a brief cognitive screening test may result in a referral to a dementia
specialist, such as a neurologist, geriatrician, or geriatric psychiatrist. Some countries have recently recommended
that brief cognitive screening tests be administered to all older adults in order to identify asymptomatic individuals who
may have underlying undiagnosed cognitive impairment (Cordell 2013), although the utility of routine screening of
asymptomatic individuals for dementia in primary care settings is controversial (UK National Screening Committee 2015).
The Mini-Cog would most often be used in most clinical settings as an initial screening test for dementia and not to arrive at a
definitive diagnosis of dementia on its own. However, in the current review we evaluated the diagnostic test accuracy of the
Mini-Cog when compared to a reference standard diagnosis of dementia to determine the accuracy of the Mini-Cog in
keeping with previous Cochrane Reviews of diagnostic test accuracy of dementia cognitive tests.
Alternative test(s)
We will not be including alternative tests in this review because there are currently no standard tests available for the
diagnosis of dementia. The diagnostic test accuracy of other cognitive tests is the subject of separate reviews (Creavin 2016;
Davis 2015; Harrison 2014; Hendry 2014).
Cochrane Dementia and Cognitive Improvement (CDCI) is in the process of conducting a series of diagnostic test accuracy
reviews of biomarkers and scales. CDCI is conducting reviews on individual tests compared to a reference standard and they
plan to compare the results of different tests in an overview.
Rationale
Most individuals with dementia are first assessed and diagnosed in primary care settings (Prorok 2013). Individuals
with dementia or cognitive disorders may present to primary care providers with cognitive symptoms although
primary care providers may not identify older adults with cognitive symptoms in routine brief clinical encounters (Bradford
2009; Connolly 2011). Some studies have found that in primary care the majority of older adults with dementia are
undiagnosed (Boustani 2005; Connolly 2011; Sternberg 2000) and mild dementia is particularly under-diagnosed (Van den
Dungen 2011). Accurate diagnosis of dementia is important in order to initiate dementia therapeutics including both
non-pharmacological treatments and pharmacological treatments such as cholinesterase inhibitors (Birks 2006; Rolinski
2012) and memantine (McShane 2009). Early diagnosis and treatment of dementia may also have long-term clinical
benefits for the patient and his or her caregivers during the course of disease progression (Bennett 2003; Prorok 2013; 
Thies 2012). Routine screening of all older adults for dementia in primary care using cognitive screening tests appears
to improve dementia case detection rates when compared to usual care without routine screening of older adults (Eichler
2015). Comprehensive evaluation conducted by psychologists or dementia physician specialists such as general
psychiatrists, geriatric psychiatrists, geriatricians, or neurologists using standardized diagnostic criteria is considered
the reference standard for diagnosing dementia in older adults. However, access to these specialized resources is
scarce and expensive and as such they are not practical to be used routinely in the evaluation of cognitive complaints
(Pimlott 2009; Yaffe 2008). While there are some cognitive tests that can be performed by healthcare providers who
are not dementia specialists, many of these tests are time consuming and may not be practical to use routinely in
primary care settings (Brodaty 2006; Pimlott 2009). As such, brief but relatively accurate cognitive screening tests are
required for healthcare providers in primary care settings as an initial test to identify individuals who may require more in-
depth evaluation of cognition either in primary care or in specialist settings.
The sensitivity and specificity of such brief screening tests are likely to vary depending upon the setting in which
they are used (Holsinger 2007). If the Mini-Cog was used in primary care settings, it could allow healthcare
professionals or lay people to initially assess older adults for the possible presence of dementia. Individuals that
screen positive for cognitive impairment on the Mini-Cog would then be further investigated for the presence of
dementia using additional cognitive tests or other investigations. Given that the Mini-Cog is brief, widely available,
easy to administer, and has been reported to have reasonable test accuracy properties (Brodaty 2006; Ismail 2010; Lin 2013;
Lorentz 2002; Milne 2008) it may be well suited for use as an initial cognitive screening test in primary care, and has
already been recommended as a suitable test for primary care dementia screening programmes in some countries (Cordell
2013). Other cognitive tests that may also be suitable for use in primary care settings include the Mini-Mental State
Examination (MMSE) (Holsinger 2007), the General Practitioner Assessment of Cognition (GPCOG), or the Memory
Impairment Screen (Brodaty 2006), however each of these take longer to administer, and may be biased by
language, culture, and education level (Matallana 2011) in contrast to the Mini-Cog. The current review will examine the
diagnostic accuracy of the Mini-Cog in primary care settings. Separate DTA reviews are being undertaken for the Mini-
Cog in community (Fage 2015) and secondary care settings (Chan 2014).
Objectives 
To determine the diagnostic accuracy of the Mini-Cog for diagnosing Alzheimer's disease dementia and related dementias in
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a primary care setting.
Secondary objectives
To investigate the heterogeneity of test accuracy in the included studies and potential sources of heterogeneity. These
potential sources of heterogeneity will include the baseline prevalence of dementia in study samples, thresholds used to
determine positive test results, the type of dementia (Alzheimer's disease dementia or all causes of dementia), and aspects
of study design related to study quality.
To identify gaps in the evidence where further research is required.
Methods 
Criteria for considering studies for this review
Types of studies 
We included all cross-sectional studies from primary care settings with well-defined populations that used the Mini-Cog as an
index cognitive test compared to a reference standard for the diagnosis of dementia. Case-control studies were not included
in this review. Studies had to use a reference standard to determine whether or not dementia was present. Studies used the
Mini-Cog as an initial cognitive test for dementia and not for the confirmation of a diagnosis of dementia. When possible,
studies administered the index and reference tests to individuals where their diagnosis was not already known, although
some studies may have used the test on people with a previously known diagnosis of Alzheimer's disease or a related
dementia.
Participants
Study participants presented in a primary care setting and may or may not have been ultimately diagnosed with Alzheimer's
disease or all-cause dementia following additional evaluation. Participants may have had cognitive complaints or dementia at
baseline although their cognitive status was not known to the individual administering the Mini-Cog or the reference standard.
Studies on participants with a developmental disability, which prevented them from completing the Mini-Cog, were excluded.
Index tests
Mini-Cog test
The Mini-Cog consists of two components: a three-word recall task that assesses memory and the clock drawing test
that assesses cognitive domains such as cognitive function, language, visual-motor skills and executive function. The
standard scoring system involves assigning a score of 0 to 3 points on the word recall task for the correct recall of 0,
1, 2, or 3 words, respectively. The clock drawing test is scored as being either 'normal' or 'abnormal'. A positive test
on the Mini-Cog (i.e. indicating a possible diagnosis of dementia) is assigned if the delayed word recall score is 0 out
of 3, or if their delayed recall score is either 1 or 2 and their clock drawing test is abnormal. A score of 3 on the
delayed word recall or 1 to 2 on the word recall with a normal clock drawing is considered a negative test (i.e. no
dementia is present) (Borson 2000).
Studies must have included the results of the Mini-Cog. We planned to examine the potential effects of multiple scoring
algorithms through subgroup analyses, although there were an insufficient number of studies identified to complete this
analysis in our review.
Target conditions
The primary target condition of interest for this review was any stage of Alzheimer's disease or all-cause dementia, which in
primary care settings would most commonly be caused by Alzheimer's disease, vascular dementia, or some combination of
these two pathologies.
Reference standards
While a definitive diagnosis can only be made post-mortem at autopsy, there are clinical reference standard criteria for
the diagnosis of the different forms of dementia. All dementia diagnostic criteria require that an individual has impairment
in multiple areas of cognition that results in difficulties in daily functioning which is not directly caused by either the
effects of a substance or general medical condition. We have included several potential reference standards for the
diagnosis of all-cause dementia or specific types of dementia. All-cause dementia is commonly diagnosed using the
Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) (APA 2000), DSM-5 criteria for major neurocognitive
disorder (APA 2013), or the International Classification of Diseases (ICD) diagnosis of dementia (WHO 2010). The
standard clinical diagnostic criteria commonly used for Alzheimer's disease dementia include the National Institute
of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders
Association (NINCDS-ADRDA) for probable or possible Alzheimer's disease dementia (McKhann 1984; McKhann 2011
). Diagnostic criteria for other types of dementia include the National Institute of Neurological Disorders and Stroke
and Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINCDS-AIREN) criteria for
vascular dementia (Roman 1993), standard criteria for dementia with Lewy bodies (McKeith 2005) and for
frontotemporal dementia (McKhann 2001).
Search methods for identification of studies 
Electronic searches 
We initially searched up to September 2012. Four subsequent updates to the initial search was performed using the same
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search methods: January 2013, February 2015, January 2016, and January 2017. We searched the Cochrane Dementia and
Cognitive Improvement Register of Diagnostic Test Accuracy Studies that is currently under development, MEDLINE
(OvidSP) (1950 to January 2017), Embase (OvidSP) (1974 to 31 January 2017), BIOSIS Previews (Thomson Reuters Web
of Science) (1926 to January 2017), Science Citation Index (Thomson Reuters Web of Science) (1945 to January 2017),
PsycINFO (OvidSP) (1806 to January week 4 2017), and LILACS (BIREME) (January 2017) (for results of the database
search, see Figure 1). See Appendix 1 for details of the sources searched, the search strategies used and the
number of citations retrieved, and to view the 'generic' search that is used regularly for Cochrane Dementia and
Cognitive Improvement's Register. Similarly, we designed structured search strategies using search terms
appropriate for each database. Controlled vocabulary such as MeSH terms and EMTREE were used where
appropriate. We made no attempt to restrict studies based on the sampling frame or setting in the searches that we
developed. This was meant to maximize the sensitivity and allow inclusion to be assessed on the basis of
population-based sampling at testing (see ‘Selection of studies’, below). We did not use search filters (collections of
terms aimed at reducing the number of studies that need to be screened) as an overall limiter because those
published have not proved sensitive enough (Whiting 2011). We did not apply any language restriction to the electronic
searches.
A single review author with extensive experience in systematic reviews performed the initial searches. Two review authors
independently screened abstracts and titles.
Searching other resources 
We searched the reference lists of all relevant studies for additional relevant studies, since this has been
reported to be a useful method to minimize overlooking potentially relevant studies for complex reviews (Greenhalgh 2005; 
Horsely 2011). We also used these studies to search electronic databases to identify additional studies through the use of
the related article feature. We asked research groups authoring studies that were used in the analysis for unpublished data.
Data collection and analysis 
Selection of studies 
Studies had to address the following.
Make use of the Mini-Cog as a cognitive test in a primary care setting.
Include patients from a primary care setting who may or may not have dementia or cognitive complaints.
Clearly explain how a diagnosis of dementia was confirmed according to a reference standard such as the DSM IV-TR,
DSM-5, or NINCDS-ADRDA at the same time or within the same four-week time period that the Mini-Cog was
administered. Formal neuropsychological evaluation or neuroimaging was required for a diagnosis of dementia.
We first selected articles based on the abstract and title. Two review authors independently located the selected articles and
assessed them for inclusion. A third review author resolved disagreements.
Data extraction and management
Two review authors extracted the following data from all included studies.
Author, journal, and year of publication.
Scoring algorithm for the Mini-Cog including cut-points used to define a positive screen; method of Mini-Cog
administration, including who administered and interpreted the test and their training.
Reference criteria and method used to confirm diagnosis of Alzheimer's disease or all-cause dementia.
Baseline demographic characteristics of the study population including age, gender, ethnicity, spectrum of presenting
symptoms, comorbidity, educational achievement, language, baseline prevalence of dementia, country, ApoE status,
methods of participant recruitment and sampling procedures.
Length of time between administration of index test (Mini-Cog) and the reference standard.
The sensitivity and specificity, and positive and negative likelihood ratios, of the index test in defining dementia.
Version of translation (if applicable).
Prevalence of dementia in the study population.
Assessment of methodological quality
To assess data quality we used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria (Whiting 2011).
The QUADAS-2 criteria contain assessment domains for patient selection, the index test, reference test, and flow and timing.
Each domain has suggested signalling questions to assist with the assessment of risk of bias for each domain. The potential
risk of bias associated with each domain is rated as being at high, low, or uncertain risk of bias. In addition, using the guide
provided in QUADAS-2, we determined the applicability of the study to the review question for each domain. We used a
standardized 'Risk of bias' template to extract data on the risk of bias for each study using the form provided by the UK
Support Unit Cochrane Diagnostic Test Accuracy group. See Appendix 2 for details. We summarized quality
assessment results using the methodological quality summary table and methodological summary graph in Review
Manager 5 (RevMan 5) (RevMan 2014).
Statistical analysis and data synthesis
We performed the statistical analysis as per the Cochrane guidelines for diagnostic test accuracy reviews (Macaskill 2010).
We planned to construct two-by-two tables for the Mini-Cog results for both all-cause dementia and Alzheimer's disease
dementia where this information was available.
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We entered data from individual studies including the true positives (TP), true negatives (TN), false positives (FP), and
false negatives (FN) into RevMan 5. We determined these values by comparing the rates of TP, TN, FP, and FN for
individuals with all-cause dementia when compared to individuals without any form of dementia. For the primary
analysis, we compared the diagnosis of all-cause dementia to no dementia. We also calculated the sensitivity,
specificity, positive and negative likelihood ratios, as well as measures of statistical uncertainty (e.g. 95% confidence
intervals) from the raw data for the primary analysis of dementia when compared to no dementia in RevMan 5. We
presented the data from each study graphically by plotting sensitivities and specificities on a coupled forest plot. If
multiple thresholds were reported for the Mini-Cog, we planned to use the hierarchical summary receiver operating
characteristic (HSROC) method of Rutter and Gastconis for the meta-analysis (Rutter 2001). We had initially planned a
meta-analysis for this review although, due to a limited number of studies and methodological limitations present in the
included studies, we did not undertake a meta-analysis as a part of the final review.
Investigations of heterogeneity
The potential sources of heterogeneity that we intended to examine included the baseline prevalence of cognitive
impairment in the target population, the cut-points used to determine a positive test result, the reference standard used
to diagnose dementia, the type of dementia (Alzheimer's disease dementia or all-cause dementia), the severity of
dementia in the study sample (using dementia severity assessment scales such as the Clinical Dementia Rating (Morris
1993) scale or the Global Deterioration Scale (Reisberg 1982)), and aspects related to study quality as assessed with the
QUADAS-2.
To investigate the effects of the sources of heterogeneity, we planned to complete subgroup analyses. These involved visual
examination of the forest plot of sensitivity and specificity and the receiver operating characteristic (ROC) plot within each
subgroup (for example baseline prevalence, type of dementia, etc). Additionally, we planned a formal analysis using the
HSROC model. This model can be extended to include covariates in order to assess whether threshold, accuracy, or the
shape of the summary ROC (SROC) curve varies with participant or study characteristics. However, given the small number
of studies included in our review and methodological limitations of studies we were unable to complete these planned
subgroup analyses.
Sensitivity analyses
We planned to perform a sensitivity analysis in order to investigate the influence of study quality on the overall diagnostic
accuracy of the Mini-Cog test. We did not perform the sensitivity analysis as we did not undertake a meta-analysis of the
results.
Assessment of reporting bias
We had not planned to assess reporting bias because of current uncertainty about how it operates in test accuracy studies
and the interpretation of existing analytical tools such as funnel plots.
Results 
Results of the search
The results of the literature search are outlined below in Figure 1. A review of the electronic databases on four
occasions between 2012 and 2017 identified a total of 292 articles. The same search strategy was employed for this
review that was used in separate reviews of the Mini-Cog in the community setting (Fage 2015) and secondary care
setting (Chan 2014). After removal of duplications, two review authors independently reviewed a total of 187 abstracts and
citations for inclusion criteria and suitability for inclusion in the final review.
We reviewed a total of 59 full-text articles for eligibility to be included in the final review. Of these 59 articles, we excluded 55
due to a lack of a reference standard (N = 22), failure to include the Mini-Cog as an index text (N = 6), duplicate publications
(N = 6), incorrect setting (N = 17), or lack of sufficient data to be included in the review (N = 4).
The search identified four independent studies from four different study reports (Carnero-Pardo 2013; Fuchs 2012; 
Holsinger 2012; McCarten 2012). The characteristics of the studies are outlined in the Summary of findings table 1. These
four studies included a total of 1517 participants and there was heterogeneity in the baseline prevalence of dementia across
the studies, which ranged from 5% to 90%. Additional details regarding the design, setting, population, target condition and
reference standard of each included study can be found in the Characteristics of included studies section.
Methodological quality of included studies
The results of the QUADAS-2 assessment for the four studies are summarized in Figure 2 and the details of the risk of bias
assessment for each of the included studies are presented in Figure 3. We judged three of the four studies as being
at a high risk of bias in the patient selection domain (Carnero-Pardo 2013; Fuchs 2012; McCarten 2012) as they did not enrol
a consecutive or random sample of patients. For Fuchs 2012, it was unclear whether or not a case-control design was
avoided and the study failed to avoid inappropriate exclusions, thus introducing a high risk of patient selection bias. While all
the included studies used the Mini-Cog as the index test, McCarten 2012 adjusted the threshold of a positive screen in order
to increase the sensitivity of the test by considering a positive screen on the Mini-Cog for possible dementia being 3 or fewer
points compared to the usual scoring of 2 or fewer points. We rated the risk of bias for the assessment of the reference
standard as unclear for both Fuchs 2012 and McCarten 2012, as it was unclear whether the reference standard
assessment results had been interpreted without knowledge of the Mini-Cog results. We rated only one study as
being at low risk of bias on all the QUADAS-2 domains (Holsinger 2012).
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Findings
There were four study reports on four unique study populations that were selected for the final review (Carnero-Pardo 2013; 
Fuchs 2012; Holsinger 2012; McCarten 2012). The Characteristics of included studies section of this review and Table 1
include a summary of the included studies. Additional features of these studies are also summarized in Summary of findings
table 1. The baseline prevalence of dementia in the overall study samples varied from 5.0% (Fuchs 2012) to 90.3%
(McCarten 2012). Two studies randomly recruited participants from Veteran Affairs Medical Centres either from
routinely scheduled primary care appointments (McCarten 2012) or electronic medical records (Holsinger 2012), one
study evaluated a random sample of medical records from primary practices in a defined geographic area (Fuchs 2012
), and another study recruited from four primary care sites in two cities (Carnero-Pardo 2013). The McCarten 2012 recruited
individuals from primary care sites who either tested positive for possible dementia on the Mini-Cog as part of a dementia
screening programme or those individuals who tested negative on the Mini-Cog but who requested additional evaluation of
their cognition. The process for selection of participants in the McCarten 2012 study likely contributed to the high prevalence
of dementia in this study, which was reported as 90.3%. Given that the McCarten 2012 study included individuals
who initially tested negative and positive on the Mini-Cog test, we decided to include it in the final review. Two
studies excluded individuals with known cognitive impairment (Carnero-Pardo 2013; McCarten 2012) and another two
excluded individuals with a history of dementia at baseline (Fuchs 2012; Holsinger 2012). All studies used the DSM-IV-
TR as the reference standard for the diagnosis of dementia and two studies based dementia diagnosis on additional
reference standards, NINCDS-ADRDA and NINCDS-AIREN, as well (Fuchs 2012, Holsinger 2012). The diagnosis of
dementia was agreed upon by consensus between two or more clinicians or researchers in all four studies. All studies used
the original scoring system for the Mini-Cog as proposed by Borson 2000 except for McCarten 2012, which used an
adjusted scoring with a cut-off of 3 or lower to indicate a positive test for dementia to increase the sensitivity of the
Mini-Cog compared to the usual cut-off of 2 or lower. Three studies reported on the gender distribution of
participants, with two studies reporting a majority of participants being female (Carnero-Pardo 2013; Fuchs 2012)
while one study reported a very low prevalence of female participants (Holsinger 2012).
The extracted data for each study, including sensitivity and specificity, are summarized in Summary of findings table 1 and in
the forest plot presented in Figure 4. The sensitivities of the Mini-Cog in the individual studies were reported as 1.00
(Carnero-Pardo 2013), 1.00 (Fuchs 2012), 0.76 (Holsinger 2012) and 0.84 (McCarten 2012). The specificity of the
Mini-Cog varied in the individual studies and was 0.40 (Carnero-Pardo 2013), 0.85 (Fuchs 2012), 0.73 (Holsinger 2012
) and 0.27 (McCarten 2012). The values for the positive and negative predictive values are summarized in Summary of
findings table 1. Meta-analysis of the diagnostic test accuracy of the Mini-Cog was initially planned in this review, although
due to the small number of studies and methodological limitations of included studies, we did not perform a meta-analysis.
The small number of studies, significant heterogeneity between the studies, and overall poor quality of most of the included
studies precluded the use of meta-analysis to arrive at pooled estimates for the diagnostic test accuracy. The planned
evaluations of heterogeneity and subgroup analyses were also not undertaken for these same reasons.
Discussion 
Summary of main results
Overall we found a small number of studies that evaluated the test accuracy of the Mini-Cog in primary care settings. The
reported sensitivities and specificities of the Mini-Cog varied significantly between studies, likely due to underlying
differences in study populations and research methods utilized across the different studies. Of the included studies, only one
study was of high quality with the remaining studies having methodological limitations that may have contributed to an
overestimation of the accuracy of the Mini-Cog in primary care. The heterogeneity of the study samples and methodological
limitations present in the majority of the studies precluded formal meta-analyses of study results and further analysis of some
of the factors related to study design that may have affected the accuracy of the Mini-Cog.
The one study in our review that was of high quality demonstrated that the accuracy of the Mini-Cog has a
sensitivity of 0.76 and specificity of 0.73 (Holsinger 2012). There is no agreed value for the sensitivity and specificity of
cognitive screening tests in primary care settings. In primary care, it would be anticipated that the Mini-Cog may be used
initially as a screening test to identify individuals who would benefit from additional cognitive evaluation for dementia. In this
situation, a brief test that has high sensitivity may be desirable. The sensitivity of the Mini-Cog reported in the one high-
quality study identified in this review may not be high enough for the Mini-Cog to be useful in this setting. One potential way
that the sensitivity of the Mini-Cog could be improved would be to modify the cut-point on Mini-Cog to increase its sensitivity,
such as in McCarten 2011. Changing the cut-point on the Mini-Cog to improve its sensitivity would also likely reduce the
specificity of Mini-Cog, which would also need to be considered when using the Mini-Cog in clinical settings. Although
Holsinger 2012 reported that there was no statistical difference in the sensitivity of the Mini-Cog when compared to the
Modified Mini-Mental State (3MS), the sensitivity of the 3MS was reported to be 0.86, which may be interpreted as a clinically
significant difference in accuracy when compared to the sensitivity of the Mini-Cog from the same study. The remaining
studies of the Mini-Cog in our review demonstrated higher sensitivities although these results must be interpreted with
caution, as the remaining studies had methodological limitations that may have resulted in biased estimates of the sensitivity
compared to Holsinger 2012. The low specificity of the Mini-Cog reported in most studies would also make it unsuitable as a
confirmatory test for dementia.
Multiple reviews of cognitive screening tests in primary care settings have identified the Mini-Cog as a potentially
appropriate cognitive test for primary care settings (Brodaty 2006; Ismail 2010; Lorentz 2002; Milne 2008; Tsoi 2015).
These previous reviews have identified that the Mini-Cog has some potentially attractive features as a cognitive test
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for primary care, such as being relatively brief and easy to measure and, in some studies, the sensitivity and
specificity of the Mini-Cog may appear to be adequate for use in this setting. However, one important limitation of
these previous reviews is that the quality of the individual studies evaluating the Mini-Cog was not taken into
consideration when evaluating its accuracy. Based on the small number of included studies and the quality of these
studies in this review, there is limited information regarding the accuracy of the Mini-Cog for the diagnosis of
Alzheimer's disease and other forms of dementia in primary care. Although the Mini-Cog has been recommended as
a test in primary care dementia screening programmes (Cordell 2013), at this time the existing evidence to support the
routine use of the Mini-Cog as a screening test in primary care is insufficient.
In addition, one feature common to all the included studies in this review may have also introduced a potential source of bias.
All studies used a version of the Mini-Cog that obtained the three-word recall component of the Mini-Cog as part of a larger
neuropsychological test (i.e. the three-word recall from the MMSE). The accuracy of the Mini-Cog to diagnose dementia may
have differed depending on whether the component tests were administered by themselves or if the results of the Mini-Cog
were derived from the results of more comprehensive testing. The three-word recall component of the Mini-Cog may be more
sensitive and less specific when incorporated into a longer test battery. There may be a greater delay between registration of
the three words and the recall task when this is incorporated into a longer test battery, compared to having the word recall
task administered in isolation.
Strengths and weaknesses of the review
Strengths of our review include our use of a standardized search of electronic databases to identify both published and
potentially unpublished studies evaluating the Mini-Cog. We also used consistent data extraction processes throughout the
review process. Importantly, we included an assessment of study quality, which identified that the majority of included studies
had major methodological limitations and only one study was assessed at low risk of bias on all quality domains. In
comparing the sensitivity reported in each study with the quality of studies, the three studies that were assessed as lower
quality reported higher sensitivities than the one study that was found to be of higher quality study. Therefore, the results of
the accuracy of the Mini-Cog in each study should be interpreted with caution and the accuracy of the Mini-Cog in some
studies is potentially overestimated due to these methodological limitations. An additional limitation of this review was that we
were unable to assess the accuracy of the Mini-Cog in different types of dementia as initially planned. The Mini-Cog may be
more accurate in some forms of dementia, such as Alzheimer's disease, where memory is affected to greater extent early in
the dementia process as compared to other types of dementia.
Applicability of findings to the review question
The Mini-Cog would most commonly be used in primary care settings as a screening test to identify individuals who
may or may not have identified cognitive complaints or dementia. Individuals testing positive on the Mini-Cog would
then likely be evaluated with additional cognitive tests in primary care or referred to specialists for further evaluation.
Given the intended use of the Mini-Cog in the diagnostic process as a screening tool, only two studies evaluated the
Mini-Cog as intended for use in most primary care settings to screen asymptomatic individuals for undetected
dementia (Fuchs 2012; Holsinger 2012). Therefore, the results of some of the studies included in this review may not
apply readily to the intended use of the Mini-Cog in primary care settings. Additionally, the use of the Mini-Cog as a
diagnostic tool was the focus of separate reviews in the community setting (Fage 2015) and secondary care setting (Chan
2014).
Authors' conclusions 
Implications for practice 
At the present time, there is insufficient evidence to recommend for or against the Mini-Cog as a diagnostic test for
Alzheimer's disease dementia and related forms of dementia in primary care settings. While the Mini-Cog has been
recommended as a potential diagnostic test for dementia in primary care settings (Cordell 2013; Brodaty 2006; Ismail 2010; 
Milne 2008; Lorentz 2002), based on the small number of published studies, methodological limitations present in
the majority of studies, and modest sensitivity and specificity of the Mini-Cog in one high-quality study (Holsinger 2012),
the evidence for the routine use of the Mini-Cog as a cognitive diagnostic test in primary care is very limited. While the
Mini-Cog is brief and relatively easy to administer in primary care settings, the limited information currently available
about the accuracy of the Mini-Cog makes it of questionable clinical utility. There is also limited information about the
accuracy of the Mini-Cog in other settings (Fage 2015). Furthermore, other brief cognitive tests for use in primary care
cannot be recommended, since only a small number of studies have evaluated these tests in primary care (Davis 2015; 
Harrison 2014).
Implications for research 
Additional research is required to determine the accuracy of the Mini-Cog in primary care settings. Future studies
should incorporate strong methodological study designs to minimize the risks of bias, which are potentially present in
the existing published studies. This includes testing the Mini-Cog as originally described and also through recruitment
of a random sample of patients from primary care settings. The accuracy of the Mini-Cog when compared to other
dementia tests that would commonly be used in primary care settings such as the Mini-Mental State Exam (Creavin 2016
) or the Montreal Cognitive Assessment (Creavin 2016) also needs to be evaluated.
Acknowledgements 
The authors would like to thank Anna Noel-Storr for her assistance with electronic database searches and Sue Marcus for
DTA 12 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting
9 / 40
her assistance with the registration and co-ordination of the editorial reviews of the protocol and final review.
Contributions of authors 
DS wrote the draft of the protocol and contributed to revisions of the protocol. DS, CC, SG, NH, NS, VN and BF all
contributed to revising the protocol and the final protocol.
Declarations of interest 
DS: no conflicts of interest to declare
CC: no conflicts of interest to declare
SG: no conflicts of interest to declare
NH: no conflicts of interest to declare
NS: no conflicts of interest to declare
VN: no conflicts of interest to declare
BF: no conflicts of interest to declare
Differences between protocol and review 
The meta-analysis, subgroup analyses and investigation of heterogeneity initially described in the protocol were not
undertaken in the final review due to the small number of studies and the methodological limitations that were observed in
the included studies.
Published notes 
Characteristics of studies
Characteristics of included studies 
Carnero-Pardo 2013
Patient Selection
A. Risk of Bias
Patient Sampling
Patients were recruited from 2 cities in Spain, Madrid and
Granada. There was 1 site in Madrid and 3 unique sites in
Granada. Neuropsychological testing for the reference
standard of all participants was completed in a tertiary care
setting. The study procedures for the Madrid and Granada
sites differed and the information from the Granada site
was used in the analysis.
Was a consecutive or random sample of patients enrolled? No
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? High risk
B. Concerns regarding applicability
Patient characteristics and setting
Participants were prospectively identified from
primary care by primary care physicians
identifying individuals who presented with
cognitive complaints or who were suspected of
having cognitive disorders by their primary care
physicians. Individuals with known cognitive
impairment prior to administration of the Mini-Cog
and reference standard were excluded.
Number of participants: dementia: 49, no
dementia: 93
Participant mean age (SD): 72.1 (11.4)
Gender: 103 women, 39 men
Education: < primary school: 72 (50.7%)
Dementia: 49 (34.5%), no dementia: 93 (65.5)
Mean MMSE scores (SD): 19.9 (5.7)
Are there concerns that the included patients and setting do not match the
review question? High
Index Test
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Index tests
Mini-Cog was derived from the MMSE and clock drawing test. In the Granada subsample, the Mini-
Cog was performed independent of the reference standard assessment and only information from the
Granada sample was used for the analysis.
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Dementia according to DSM IV TR
performed by 2 neurologists
Is the reference standards likely to correctly classify the target condition? Yes
Were the reference standard results interpreted without knowledge of the
results of the index tests? Yes
Could the reference standard, its conduct, or its interpretation have introduced
bias? Low risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
Timing of index and reference test
unclear
Was there an appropriate interval between index test and reference standard? Unclear
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Notes
Notes  
Fuchs 2012
Patient Selection
A. Risk of Bias
Patient Sampling
Participants were randomly selected from
medical records of 138 primary practices in
1/6 German metropolitan study centres.
Patients with baseline dementia were
excluded. Participants had to have at least 1
contact with primary care physician within the
year preceding enrolment.
Was a consecutive or random sample of patients enrolled? Yes
Was a case-control design avoided? Unclear
Did the study avoid inappropriate exclusions? No
Could the selection of patients have introduced bias? High risk
DTA 12 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting
11 / 40
B. Concerns regarding applicability
Patient characteristics and setting
Patients who were home-care visits only,
residing in nursing home, or having illness
potentially fatal within 3 months, were
excluded. Patients with insufficient German-
speaking capabilities, deafness, or blindness
were also excluded. All patients within
participating practices aged 75-89 years old
were eligible to be selected.
Number of participants: dementia: 21, no
dementia: 402
Participant mean age (SD): dementia: 82.4
(3.4), no dementia: 82.4 (3.2)
Female gender: dementia (68.7%), no
dementia (61.9%)
Education level: variable, dementia "low
education" (62.2%), no dementia "low
education" (61.9%)
Are there concerns that the included patients and setting do not match the
review question? Low concern
Index Test
Index tests Mini-Cog administered with original scoring, as per Borson 2000
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Dementia based on the criteria of DSM-IV,
NINCDS-ADRDA, NINCDS-AIREN as
evaluated in a conference between the
interviewer and study co-ordinator.
Evaluation based on SIDAM test results,
interview data, informant's information,
primary care provider survey and SISCO
results.
Is the reference standards likely to correctly classify the target condition? Yes
Were the reference standard results interpreted without knowledge of the
results of the index tests? Unclear
Could the reference standard, its conduct, or its interpretation have introduced
bias? Unclear risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing Data available for all except 9 participants.
Was there an appropriate interval between index test and reference standard? Yes
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? No
Could the patient flow have introduced bias? Low risk
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Notes
Notes  
Holsinger 2012
Patient Selection
A. Risk of Bias
Patient Sampling
Random sample of primary care patients
without known history of dementia. Patients,
≥ 65 years were randomly sampled from
electronic medical records of 3 Department
of Veterans Affairs primary care clinics
close to Durham, N.C., USA. Participants
were required to have at least 1 primary
care visit in the preceding 18 months.
Was a consecutive or random sample of patients enrolled? Yes
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? Low risk
B. Concerns regarding applicability
Patient characteristics and setting
Excluded individuals with chart diagnosis of
dementia or psychotic illness. The remaining
population of individuals > 65 years were
randomly selected. All potentially eligible female
participants were selected due to the small
numbers of women in the primary care
locations. Patients with severe visual and
hearing impairment, unable to recall an
informant for supplemental cognitive history,
active alcohol or drug abuse, unstable medical
conditions and insufficient English fluency were
excluded from the study.
Number of participants: dementia: 21, no
dementia: 362
Participant mean age (SD): dementia: 79.0
(5.1), no dementia: 74.2 (6.5)
Female gender number (%): dementia: 1
(4.8%), no dementia: 30 (8.3%)
Years of education (SD): dementia: 11.1 (3.9),
no dementia: 13.5 (3.2)
Are there concerns that the included patients and setting do not match the
review question? Low concern
Index Test
Index tests Mini-Cog scored with original scoring algorithm, as per Borson 2000
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
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A. Risk of Bias
Target condition and reference standard(s)
Diagnosis of dementia based on the criteria of DSM-IV-TR,
NINDS-ADRDA, NINCDS-AIREN. Evaluated by a
consensus panel of specialists from neurology, internal
medicine, geriatric psychiatry and cognitive neuroscience.
Evaluations were based on clinical interview, history by
informant, neuropsychological testing, standardized
neurology exam and review of the electronic medical
record.
Is the reference standards likely to correctly classify the target
condition? Yes
Were the reference standard results interpreted without
knowledge of the results of the index tests? Yes
Could the reference standard, its conduct, or its interpretation
have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
Data were not available for 9/639
patients selected. 1242 patients were
contacted, patients with a variable
informant, who matched the eligibility
guidelines and showed up for the
evaluation totaled 639.
Was there an appropriate interval between index test and reference standard? Yes
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Notes
Notes  
McCarten 2012
Patient Selection
A. Risk of Bias
Patient Sampling
Participants aged ≥ 70 years without prior
cognitive impairment, who were not terminally ill
were randomly selected from 7 Veteran Affairs
Medical Centers during routinely scheduled
primary care appointments. Individuals who were
assessed by their primary care physicians as
possibly requiring additional evaluation were then
invited to receive both the index test and
evaluations to complete the reference standard
evaluation.
Was a consecutive or random sample of patients enrolled? Yes
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? High risk
B. Concerns regarding applicability
Patient characteristics and setting
Veterans, ≥ 70 years, in stable health and
able to complete the screen and without
baseline cognitive impairment were
eligible.
Are there concerns that the included patients and setting do not match the
review question? High
Index Test
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Index tests Mini-Cog with less stringent criteria of ≤ 3/5 for a positive screen to increase sensitivity
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Dementia based on DSM-IV diagnostic criteria, using
information from the results of the Montreal Cognitive
Assessment, Neuropsychiatric Inventory (NPI-Q), the
dependence scale, driving screen, caregiver needs
assessment, cognitive performance test, performance-
based functional assessment, brain imaging. Final
review of all tests in consensus conference to
determine the diagnosis.
Is the reference standards likely to correctly classify the target
condition? Yes
Were the reference standard results interpreted without knowledge
of the results of the index tests? Unclear
Could the reference standard, its conduct, or its interpretation have
introduced bias? Unclear risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
8342 people were randomly selected for
screening and 8063 agreed to participate.
698 either failed the screening and
accepted further evaluation or passed the
screening and requested further
evaluation; these received both the index
and reference standards. 1501 failed the
screen and refused further testing and
5864 passed screening and did not
request further evaluation.
Was there an appropriate interval between index test and reference standard? Unclear
Did all patients receive the same reference standard? No
Were all patients included in the analysis? No
Could the patient flow have introduced bias? High risk
Notes
Notes  
Footnotes
DSM IV: Diagnostic and Statistical Manual of Mental Disorders Fourth Edition; DSM IV TR: Diagnostic and Statistical Manual
of Mental Disorders Fourth Edition (text revision); MMSE: Mini-Mental State Exam; NINCDS-ADRDA: National Institute of
Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association;
NINDS-AIREN: National Institute of Neurological Disorders and Stroke and Association Internationale pour la Recherche et
l'Enseignement en Neurosciences; SIDAM: Structured Interview for the Diagnosis of Dementia of the Alzheimer Type, Multi-
Infarct Dementia, and Dementias of Other Aetiology According to DSM-III-R, DSM-IV, and ICD-10; SISCO: SIDAM score.
Characteristics of excluded studies 
Agarwal 2016
DTA 12 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting
15 / 40
Reason for exclusion Setting other than primary care
 
Alexander 2016
Reason for exclusion Setting other than primary care
 
Anderson 2012
Reason for exclusion Did not use the Mini-Cog as the index test
 
Arabi 2013
Reason for exclusion Did not use the Mini-Cog as the index test. Participants did not receive gold standard
evaluation using standardized diagnostic criteria. Did not use the Mini-Cog in a primary
care setting
 
Ashley 2004
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Borson 2000
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Borson 2002
Reason for exclusion Insufficient information. Request for additional information denied
 
Borson 2003a
Reason for exclusion Not online. Request for additional information denied
 
Borson 2003b
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Borson 2005
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Borson 2006
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Borson 2007
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Chan 2015a
Reason for exclusion Did not use reference standard for dementia
 
Chan 2015b
Reason for exclusion Did not use reference standard for dementia
 
Clionsky 2010
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Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Doerflinger 2007
Reason for exclusion Did not use the Mini-Cog as index test. Participants were not without dementia or
cognitive complaints at baseline. Did not receive gold standard evaluation using
standardized diagnostic criteria
 
Evans 2014
Reason for exclusion Did not use the Mini-Cog as an index test. Was not a cross-sectional study
 
Filho 2009
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Hanson 2016
Reason for exclusion Did not use reference standard for dementia
 
Heng 2016
Reason for exclusion Setting other than primary care
 
Hirsch 2012
Reason for exclusion Was not a cross-sectional study
 
Kallumpuram 2015
Reason for exclusion Insufficient information available because both Mini-Cog and FAQ results were
combined
 
Kamenski 2009
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Kaufer 2008
Reason for exclusion Unclear if Mini-Cog was used as an index test
 
Ketelaars 2013
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Lee 2008
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Lin 2013
Reason for exclusion Was not a cross-sectional study
 
Lorentz 2002
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Reason for exclusion Did not use Mini-Cog as an index test. Participants were not without dementia or
cognitive complaints at baseline. Did not receive gold standard evaluation using
standardized diagnostic criteria
 
Lourenco 2005
Reason for exclusion Did not use Mini-Cog as an index test. Participants were not without dementia or
cognitive complaints at baseline. Did not receive gold standard evaluation using
standardized diagnostic criteria
 
Luscher 2014
Reason for exclusion Did not use Mini-Cog as an index test. Participants were not without dementia or
cognitive complaint at baseline. Did not receive gold standard evaluation using
standardized diagnostic criteria. Was not a cross-sectional study. Did not use the Mini-
Cog in a primary care setting
 
Maklad 2016
Reason for exclusion Did not use the reference standard for dementia
 
McCarten 2011
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Milian 2012
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Milian 2013
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Mion 2014
Reason for exclusion Did not use the Mini-Cog as an index test. Participants were not without dementia or
cognitive complaint at baseline. Did not receive gold standard evaluation using
standardized diagnostic criteria. Was not a cross-sectional study
 
Montejo 2017
Reason for exclusion Did not use the reference standard for dementia
 
Moyer 2014
Reason for exclusion Did not use the Mini-Cog as an index test. Did not receive gold standard evaluation
using standardized diagnostic criteria. Was not a cross-sectional study. Unclear if
participants were without dementia or cognitive complaint at baseline
 
Norris 2016
Reason for exclusion Setting other than primary care
 
Patel 2014
Reason for exclusion Participants were not without dementia and cognitive complaint at baseline. Did not
receive gold standard evaluation using standardized diagnostic criteria. Was not a
cross-sectional study
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Perez-Mojica 2014
Reason for exclusion Unclear if the participants were without dementia and cognitive complaint at baseline.
Unclear if a gold standard evaluation using standardized diagnostic criteria was used.
Did not use the Mini-Cog in a primary care setting
 
Petrazzuoli 2013
Reason for exclusion Did not use the Mini-Cog as an index test. Participants were not without dementia and
cognitive complaint at baseline. Did not receive gold standard evaluation using
standardized diagnostic criteria. Was not a cross-sectional study. Did not use the Mini-
Cog in a primary care setting
 
Pudlo 2016
Reason for exclusion Setting other than primary care
 
Puustinen 2016
Reason for exclusion Setting other than primary care
 
Rosales-Lagarde 2016
Reason for exclusion Lack of reference test for dementia
 
Rosenbloom 2014
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Setter 2009
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Sinclair 2013
Reason for exclusion Did not receive gold standard evaluation using standardized diagnostic criteria
 
Singla 2016
Reason for exclusion Setting other than primary care
 
Skibitsky 2016
Reason for exclusion Insufficient information available to calculate sensitivity and specificity
 
Slater 2013
Reason for exclusion Participants were not without dementia or cognitive complaint at baseline
 
Steenland 2008
Reason for exclusion Did not use the Mini-Cog in a primary care setting
 
Trowbridge 2014
Reason for exclusion Setting other than primary care
 
Trowbridge 2016
DTA 12 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting
19 / 40
Reason for exclusion Setting other than primary care
 
Vega 2016
Reason for exclusion Lack of reference test
 
Yang 2016
Reason for exclusion Setting over than primary care
 
Footnotes
FAQ: frequently asked questions
Characteristics of studies awaiting classification 
Footnotes
Characteristics of ongoing studies 
Footnotes
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Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting
Population The study populations were sampled from participants identified in primary care settings.
Setting
The primary care setting was identified as representing a sample that would be presenting to primary care
settings where the Mini-Cog might be used as a screening test to identify individuals who may benefit from
additional evaluation. Studies that identified individuals in primary care where they received both the index test
and a reference standard were used.
Indext test The Mini-Cog performed in insolation or scored based on results on the clock drawing test or three-word recallwere included.
Reference
Standard Clinical diagnosis of dementia was made using recognized standard diagnostic criteria.
Studies Cross-sectional studies were included, case control studies were excluded
Study
Accuracy
(95% CI)
Number of
participants
Dementia
prevalence
Implications
Carnero-
Pardo 2013
Sensitivity:
1.00 (0.93 to
1.00)
Specificity:
0.40 (0.30 to
0.50)
142 34.5%
Participants were sampled including individuals who did have a pre-
existing history of dementia or cognitive impairment prior to assessment
with the Mini-Cog and reference standard but all participants had to have
cognitive complaints suggestive of possible undiagnosed dementia or
cognitive impairment.
Fuchs 2012
Sensitivity:
1.00 (0.84 to
1.00)
Specificity:
0.85 (0.81 to
0.89)
423 5.0%
The study excluded individuals with dementia at baseline, and those
included in the study received a 36 month follow up assessment. Thus
participants in the sample who were diagnosed with dementia were in the
early stages of the disease.
Holsinger
2012
Sensitivity:
0.76 (0.53 to
0.92)
Specificity:
0.73 (0.68 to
0.77)
383 5.5% Study involved evaluation of individuals in primary care settings without adocumented history of dementia recorded at baseline.
McCarten
2012
Sensitivity:
0.84 (0.81 to
0.87)
Specificity:
0.27 (0.16 to
0.41)
569 90.3%
Individuals with documented cognitive impairment were excluded from
screening. Sampling involved screening of all participants in primary care
and then offering further evaluation to individuals who either screened
positive or negative on initial screening and who also agreed to have
further evaluation.
Footnotes
CI: confidence interval
Additional tables 
1 Characteristics of included studies
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Study ID Country Participants(N) Setting
Mini-Cog
scoring
Reference
standard for
dementia
diagnosis
Dementia
prevalence Notes
Carnero-
Pardo
2013
Spain 142
1 primary care
location in Madrid and
3 primary care
locations in Granada,
only data from the
Granada site was
included
Standard
scoring DSM IV TR 34.5%
The clock drawing test was
incorporated into the reference
standard at the Madrid site, data
are presented for the Granada
sites only. Screening was
administered by professionals (no
further specification) except for
the clock drawing test component
in Madrid, which was performed
by a neurologist.
Fuchs
2012 Germany 423
Participants were
randomly selected
from 138 study
centres in 6
metropolitan areas in
Germany although
study reports
information from 29
sites recruited from
Dusseldorf region
Standard
scoring DSM IV 5.0%
Individuals with known dementia
were excluded from the study.
Study evaluated accuracy of the
Mini-Cog in detecting incident
dementia at 36 months' follow-up
from enrolment. Screening tests
were administered by a trained
physician or psychologist.
Holsinger
2012 USA 383
Primary care locations
affiliated with the
Veterans Affairs near
Durham, North
Carolina
Standard
scoring
DSM IV and
NINCDS-
ADRDA
5.5%
Excluded individuals with a known
prior history of dementia based on
diagnoses recorded in charts. The
Mini-Cog was administered by a
research assistant.
McCarten
2012 USA 569
7 primary care
settings affiliated with
Veterans Affairs in
Minneapolis,
Minnesota
Standard
scoring DSM IV 90.3%
Participants were first screened
for possible dementia by trained
advanced practice registered
nurses based on interview during
routine visit with those who initially
screened positive being offered
additional evaluation with the
index and reference standards.
Some individuals who did not
screen positive at the initial
interview requested and received
additional evaluation.
Footnotes
DSM IV: Diagnostic and Statistical Manual of Mental Disorders Fourth Edition; DSM IV TR: Diagnostic and Statistical Manual
of Mental Disorders Fourth Edition (text revision); NINCDS-ADRDA: Neurological and Communicative Disorders and Stroke
and the Alzheimer's Disease and Related Disorders Association
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Source
Search strategy Hits retrieved
ALOIS DTA (Cochrane Dementia and Cognitive Improvement
Specialized Register) (see below for detailed explanation of what is
contained within the ALOIS register)
 
Mini-cog
September
2012: 19
January 2013:
0
1. MEDLINE In-Process and other non-indexed citations and
MEDLINE 1950 to present (January 2013) (Ovid SP)
 
1. "mini-Cog".ti,ab.
2. minicog.ti,ab.
3. (MCE and (cognit* OR dement* OR
screen* OR Alzheimer*)).ti,ab.
3. or/1-3
September
2012: 91
January 2013:
12
2. Embase
1974-2013 January 02 (OvidSP)
 
1. "mini-cog*".mp.
2. minicog*.mp.
3. 1 or 2
September
2012: 96
January 2013:
37
3. PsycINFO
1806 to January week 1 2013 (OvidSP)
 
1. minicog*.mp.
2. "mini-cog*".mp.
3. 1 or 2
September
2012: 69
January 2013:
28
4. Biosis previews 1926 to present (January 2013) (ISI Web of
Knowledge)
 
Topic=("mini-cog*" OR "minicog*")
Timespan=All Years.
Databases=BIOSIS Previews.
Lemmatization=On
September
2012: 33
January 2013:
7
5. Web of Science and conference proceedings (1945 to January
2013)
 
Topic=("mini-cog*" OR "minicog*")
Timespan=All Years.
Databases=BIOSIS Previews.
Lemmatization=On
September
2012: 93
January 2013:
20
6. LILACS (BIREME) (January 2013) "mini-cog" OR minicog [Words] September
2012: 2
January 2013:
2
Total before deduplication September
2012: 403
January 2013:
106
Total after deduplication and first assessment September
2012: 108
January 2013:
41
In addition to the above single concept search based on the Index test, Cochrane Dementia and Cognitive Improvement ran
a more complex, multi-concept search each month primarily for the identification of diagnostic test accuracy studies of
neuropsychological tests. Where possible they obtained the full texts of the studies identified. This approach is expected to
help identify those papers where the index test of interest (in this case Mini-Cog) is used and the paper contains usable data
but where Mini-Cog was not alluded to in the report's citation.
The MEDLINE strategy used is below. Similar strategies are also run in Embase and PsycINFO.
The Mini-Cog search utilized only one search concept: the index test (Mini-Cog):
1. "mini-Cog".ti,ab.
2. minicog.ti,ab.
3. (MCE and (cognit* OR dement* OR screen* OR Alzheimer*)).ti,ab.
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4. or/1-3
The MEDLINE generic search run for the Cochrane Dementia and Cognitive Improvement DTA register:
1. "word recall".ti,ab.
2. ("7-minute screen" OR “seven-minute screen”).ti,ab.
3. ("6 item cognitive impairment test" OR “six-item cognitive impairment test”).ti,ab.
4. "6 CIT".ti,ab.
5. "AB cognitive screen".ti,ab.
6. "abbreviated mental test".ti,ab.
7. "ADAS-cog".ti,ab.
8. AD8.ti,ab.
9. "inform* interview".ti,ab.
10. "animal fluency test".ti,ab.
11. "brief alzheimer* screen".ti,ab.
12. "brief cognitive scale".ti,ab.
13. "clinical dementia rating scale".ti,ab.
14. "clinical dementia test".ti,ab.
15. "community screening interview for dementia".ti,ab.
16. "cognitive abilities screening instrument".ti,ab.
17. "cognitive assessment screening test".ti,ab.
18. "cognitive capacity screening examination".ti,ab.
19. "clock drawing test".ti,ab.
20. "deterioration cognitive observee".ti,ab.
21. ("Dem Tect" OR DemTect).ti,ab.
22. "object memory evaluation".ti,ab.
23. "IQCODE".ti,ab.
24. "mattis dementia rating scale".ti,ab.
25. "memory impairment screen".ti,ab.
26. "minnesota cognitive acuity screen".ti,ab.
27. "mini-cog".ti,ab.
28. "mini-mental state exam*".ti,ab.
29. "mmse".ti,ab.
30. "modified mini-mental state exam".ti,ab.
31. "3MS".ti,ab.
32. “neurobehavio?ral cognitive status exam*”.ti,ab.
33. "cognistat".ti,ab.
34. "quick cognitive screening test".ti,ab.
35. "QCST".ti,ab.
36. "rapid dementia screening test".ti,ab.
37. "RDST".ti,ab.
38. "repeatable battery for the assessment of neuropsychological status".ti,ab.
39. "RBANS".ti,ab.
40. "rowland universal dementia assessment scale".ti,ab.
41. "rudas".ti,ab.
42. "self-administered gerocognitive exam*".ti,ab.
43. ("self-administered" and "SAGE").ti,ab.
44. "self-administered computerized screening test for dementia".ti,ab.
45. "short and sweet screening instrument".ti,ab.
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46. "sassi".ti,ab.
47. "short cognitive performance test".ti,ab.
48. "syndrome kurztest".ti,ab.
49. ("six item screener" OR “6-item screener”).ti,ab.
50. "short memory questionnaire".ti,ab.
51. ("short memory questionnaire" and "SMQ").ti,ab.
52. "short orientation memory concentration test".ti,ab.
53. "s-omc".ti,ab.
54. "short blessed test".ti,ab.
55. "short portable mental status questionnaire".ti,ab.
56. "spmsq".ti,ab.
57. "short test of mental status".ti,ab.
58. "telephone interview of cognitive status modified".ti,ab.
59. "tics-m".ti,ab.
60. "trail making test".ti,ab.
61. "verbal fluency categories".ti,ab.
62. "WORLD test".ti,ab.
63. "general practitioner assessment of cognition".ti,ab.
64. "GPCOG".ti,ab.
65. "Hopkins verbal learning test".ti,ab.
66. "HVLT".ti,ab.
67. "time and change test".ti,ab.
68. "modified world test".ti,ab.
69. "symptoms of dementia screener".ti,ab.
70. "dementia questionnaire".ti,ab.
71. "7MS".ti,ab.
72. ("concord informant dementia scale" or CIDS).ti,ab.
73. (SAPH or "dementia screening and perceived harm*").ti,ab.
74. or/1-73
75. exp Dementia/
76. Delirium, Dementia, Amnestic, Cognitive Disorders/
77. dement*.ti,ab.
78. alzheimer*.ti,ab.
79. AD.ti,ab.
80. ("lewy bod*" or DLB or LBD or FTD or FTLD or “frontotemporal lobar degeneration” or “frontaltemporal dement*).ti,ab.
81. "cognit* impair*".ti,ab.
82. (cognit* adj4 (disorder* or declin* or fail* or function* or degenerat* or deteriorat*)).ti,ab.
83. (memory adj3 (complain* or declin* or function* or disorder*)).ti,ab.
84. or/75-83
85. exp "sensitivity and specificity"/
86. "reproducibility of results"/
87. (predict* adj3 (dement* or AD or alzheimer*)).ti,ab.
88. (identif* adj3 (dement* or AD or alzheimer*)).ti,ab.
89. (discriminat* adj3 (dement* or AD or alzheimer*)).ti,ab.
90. (distinguish* adj3 (dement* or AD or alzheimer*)).ti,ab.
91. (differenti* adj3 (dement* or AD or alzheimer*)).ti,ab.
92. diagnos*.ti.
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93. di.fs.
94. sensitivit*.ab.
95. specificit*.ab.
96. (ROC or "receiver operat*").ab.
97. Area under curve/
98. ("Area under curve" or AUC).ab.
99. (detect* adj3 (dement* or AD or alzheimer*)).ti,ab.
100. sROC.ab.
101. accura*.ti,ab.
102. (likelihood adj3 (ratio* or function*)).ab.
103. (conver* adj3 (dement* or AD or alzheimer*)).ti,ab.
104. ((true or false) adj3 (positive* or negative*)).ab.
105. ((positive* or negative* or false or true) adj3 rate*).ti,ab.
106. or/85-105
107. exp dementia/di
108. Cognition Disorders/di [Diagnosis]
109. Memory Disorders/di
110. or/107-109
111. *Neuropsychological Tests/
112. *Questionnaires/
113. Geriatric Assessment/mt
114. *Geriatric Assessment/
115. Neuropsychological Tests/mt, st
116. "neuropsychological test*".ti,ab.
117. (neuropsychological adj (assess* or evaluat* or test*)).ti,ab.
118. (neuropsychological adj (assess* or evaluat* or test* or exam* or battery)).ti,ab.
119. Self report/
120. self-assessment/ or diagnostic self evaluation/
121. Mass Screening/
122. early diagnosis/
123. or/111-122
124. 74 or 123
125. 110 and 124
126. 74 or 123
127. 84 and 106 and 126
128. 74 and 106
129. 125 or 127 or 128
130. exp Animals/ not Humans.sh.
131. 129 not 130
2 Appendix 2: QUADAS-2
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Domain Patient selection Index test Reference standard Flow and timing
Description
 
Describe methods of
patient selection:
describe included
patients (prior testing,
presentation, intended
use of index test and
setting)
Describe the index
test and how it was
conducted and
interpreted
Describe the reference
standard and how it
was conducted and
interpreted
Describe any patients who did not
receive the index test(s) and/or
reference standard or who were
excluded from the 2 x 2 table (refer
to flow diagram): describe the time
interval and any interventions
between index test(s) and reference
standard
Signalling
questions
(yes, no,
unclear)
 
Was a consecutive or
random sample of
patients enrolled?
Was a case-control
design avoided?
Did the study avoid
inappropriate
exclusions?
 
Were the index test
results interpreted
without knowledge of
the results of the
reference standard?
If a threshold was
used, was it pre-
specified?
 
Is the reference
standard likely to
correctly classify the
target condition?
Were the reference
standard results
interpreted without
knowledge of the
results of the index
test?
 
Was there an appropriate interval
between index test(s) and reference
standard?
Did all patients receive the same
reference standard?
Were all patients included in the
analysis?
Risk of bias:
(high, low,
unclear)
Could the selection of
patients have introduced
bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct,
or its interpretation
have introduced bias?
Could the patient flow have
introduced bias?
Concerns
regarding
applicability:
(high, low,
unclear)
Are there concerns that
the included patients do
not match the review
question?
Are there concerns
that the index test, its
conduct, or
interpretation differ
from the review
question?
Are there concerns that
the target condition as
defined by the
reference standard
does not match the
review question?
—
Anchoring statements to assist with assessment of risk of bias
Domain 1: patient selection
Risk of bias: could the selection of patients have introduced bias? (high, low, unclear)
Was a consecutive or random sample of patients enrolled?
Where sampling is used, the methods least likely to cause bias are consecutive sampling or random sampling, which should
be stated and/or described. Non-random sampling or sampling based on volunteers is more likely to be at high risk of bias.
Weighting: high risk of bias
Was a case-control design avoided?
Case-control study designs have a high risk of bias, but sometimes they are the only studies available especially if the index
test is expensive and/or invasive. Nested case-control designs (systematically selected from a defined population cohort) are
less prone to bias but they will still narrow the spectrum of patients that receive the index test. Study designs (both cohort
and case-control) that may also increase bias are those designs where the study team deliberately increase or decrease the
proportion of participants with the target condition, for example a population study may be enriched with extra dementia
participants from a secondary care setting.
Weighting: high risk of bias
Did the study avoid inappropriate exclusions?
We will automatically grade the study as unclear if exclusions are not detailed (pending contact with study authors). Where
exclusions are detailed, we will grade the study as 'low risk' if exclusions are felt to be appropriate by the review authors.
Certain exclusions common to many studies of dementia are: medical instability; terminal disease; alcohol/substance misuse;
concomitant psychiatric diagnosis; other neurodegenerative condition. However if 'difficult to diagnose' groups are excluded
this may introduce bias, so exclusion criteria must be justified. For a community sample we would expect relatively few
exclusions. We will label post hoc exclusions 'high risk' of bias.
Weighting: high risk of bias
Applicability: are there concerns that the included patients do not match the review question? (high, low, unclear)
The included patients should match the intended population as described in the review question. If not already specified in
the review inclusion criteria, setting will be particularly important – the review authors should consider population in terms of
symptoms; pre-testing; potential disease prevalence. We will classify studies that use very selected participants or subgroups
as having low applicability, unless they are intended to represent a defined target population, for example, people with
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memory problems referred to a specialist and investigated by lumbar puncture.
Domain 2: index test
Risk of bias: could the conduct or interpretation of the index test have introduced bias? (high, low, unclear)
Were the index test results interpreted without knowledge of the reference standard?
Terms such as 'blinded' or 'independently and without knowledge of' are sufficient and full details of the blinding procedure
are not required. This item may be scored as 'low risk' if explicitly described or if there is a clear temporal pattern to the order
of testing that precludes the need for formal blinding, i.e. all (neuropsychological test) assessments were performed before
the dementia assessment. As most neuropsychological tests are administered by a third party, knowledge of dementia
diagnosis may influence their ratings; tests that are self administered, for example using a computerized version, may have
less risk of bias.
Weighting: high risk of bias
Were the index test thresholds pre-specified?
For neuropsychological scales there is usually a threshold above which participants are classified as 'test positive'; this may
be referred to as threshold, clinical cut-off or dichotomiation point. Different thresholds are used in different populations. A
study is classified as at higher risk of bias if the authors define the optimal cut-off post hoc based on their own study data.
Certain papers may use an alternative methodology for analysis that does not use thresholds and these papers should be
classified as not applicable.
Weighting: low risk of bias
Were sufficient data on (neuropsychological test) application given for the test to be repeated in an independent study?
Particular points of interest include method of administration (for example self completed questionnaire versus direct
questioning interview); nature of informant; language of assessment. If a novel form of the index test is used, for example a
translated questionnaire, details of the scale should be included and a reference given to an appropriate descriptive text, and
there should be evidence of validation.
Weighting: low risk of bias
Applicability: are there concerns that the index test, its conduct, or interpretation differ from the review question? (high, low,
unclear)
Variations in the length, structure, language, and/or administration of the index test may all affect applicability if they vary
from those specified in the review question.
Domain 3: reference standard
Risk of bias: could the reference standard, its conduct, or its interpretation have introduced bias? (high, low, unclear)
Is the reference standard likely to correctly classify the target condition?
Commonly used international criteria to assist with clinical diagnosis of dementia include those detailed in DSM-IV and
ICD-10. Criteria specific to dementia subtypes include but are not limited to NINCDS-ADRDA criteria for Alzheimer's
dementia; McKeith criteria for Lewy Body dementia; Lund criteria for frontotemporal dementias; and the NINDS-AIREN
criteria for vascular dementia. Where the criteria used for assessment are not familiar to the review authors and Cochrane
Dementia and Cognitive Improvement, this item should be classified as 'high risk of bias'.
Weighting: high risk of bias
Were the reference standard results interpreted without knowledge of the results of the index test?
Terms such as 'blinded' or 'independent' are sufficient and full details of the blinding procedure are not required. This may be
scored as 'low risk' if explicitly described or if there is a clear temporal pattern to order of testing, i.e. all dementia
assessments performed before (neuropsychological test) testing.
Informant rating scales and direct cognitive tests present certain problems. It is accepted that informant interview and
cognitive testing is a usual component of clinical assessment for dementia, however specific use of the scale under review in
the clinical dementia assessment should be scored as high risk of bias.
Weighting: high risk of bias
Was sufficient information on the method of dementia assessment given for the assessment to be repeated in an
independent study?
Particular points of interest for dementia assessment include the training/expertise of the assessor, whether additional
information was available to inform the diagnosis (for example neuroimaging, other neuropsychological test results), and
whether this was available for all participants.
Weighting: variable risk, but high risk if method of dementia assessment not described
Applicability: are there concerns that the target condition as defined by the reference standard does not match the review
question? (high, low, unclear)
There is the possibility that some methods of dementia assessment, although valid, may diagnose a far smaller or larger
proportion of participants with disease than in usual clinical practice. For example, currently the reference standard for
vascular dementia may under-diagnose compared to usual clinical practice. In this instance the item should be rated as
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having poor applicability.
Domain 4: patient flow and timing
Risk of bias: could the patient flow have introduced bias? (high, low, unclear)
Was there an appropriate interval between the index test and reference standard?
For a cross-sectional study design, there is potential for the subject to change between assessments, however dementia is a
slowly progressive disease, which is not reversible. The ideal scenario would be a same-day assessment, but longer periods
of time (for example, several weeks or months) are unlikely to lead to a high risk of bias. For delayed-verification studies the
index and reference tests are necessarily separated in time given the nature of the condition.
Weighting: low risk of bias
Did all participants receive the same reference standard?
There may be scenarios where participants who score 'test positive' on the index test have a more detailed assessment for
the target condition. Where dementia assessment (or reference standard) differs between participants this should be
classified as high risk of bias.
Weighting: high risk of bias
Were all participants included in the final analysis?
Attrition will vary with study design. Delayed verification studies will have higher attrition than cross-sectional studies due to
mortality, and it is likely to be greater in participants with the target condition. Dropouts (and missing data) should be
accounted for. Attrition that is higher than expected (compared to other similar studies) should be treated as a high risk of
bias. We have defined a cut-off of greater than 20% attrition as being high risk but this will be highly dependent on the length
of follow-up in individual studies.
Weighting: high risk of bias
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